Portal vein tumor thrombus after hepatocellular carcinoma resection
Conditions
Interventions
Group 2:TACE+Laser ablation: One week after TACE, laser ablation is given to the PVTT.
Group 1:TACE: The chemotherapeutic drugs and 2 to 10 ml lipiodol are given via hepatica propria artery. The chemotherapeutic drugs include 5-Fu 1500 mg, epirubicin 30 mg, cisplatin 30 mg.
Sponsors
Shanghai Eastern Hepatobiliary Surgery Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. PVTT after liver resection was diagnosed with at least two types of imaging findings, such as CT, MRI or color doplor findings; 2. The functions of the kidney, heart and lung and the routine test of the blood are in good condition; 3. The liver function is of grade A or B in Child-Pugh classification; 4. The patient is eligible of the trial and will show consent to the test.
Exclusion criteria
Exclusion criteria: 1. any of the parameters. WBC less than 2000/ml, Hb less than 90g/L or PLT less than 50000/ml; 2. disfunction of the heart, lung, kidney, or brain; 3. any other disease might affect the trial or 4. the patients would not sign the consent to the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| distal metastasis;overall survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| clinical presentation;laboratory findings;the changes of the PVT; | — |
Countries
China
Contacts
Public ContactLu Zhenghua
Outcome results
None listed